Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
102.93
-7.15 (-6.50%)
At close: May 7, 2026, 4:00 PM EDT
102.93
0.00 (0.00%)
Pre-market: May 8, 2026, 8:09 AM EDT
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
The 14 analysts that cover Mirum Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $127.93, which forecasts a 24.29% increase in the stock price over the next year. The lowest target is $77 and the highest is $175.
Price Target: $127.93 (+24.29%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 5 | 5 |
| Buy | 6 | 6 | 8 | 8 | 8 | 9 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 13 | 12 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $125 → $145 | Strong Buy | Maintains | $125 → $145 | +40.87% | May 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $128 → $142 | Buy | Maintains | $128 → $142 | +37.96% | May 7, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $135 → $138 | Buy | Maintains | $135 → $138 | +34.07% | May 7, 2026 |
| Baird | Baird | Buy Maintains $112 → $129 | Buy | Maintains | $112 → $129 | +25.33% | May 7, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $130 → $140 | Buy | Maintains | $130 → $140 | +36.01% | May 5, 2026 |
Financial Forecast
Revenue This Year
657.80M
from 521.31M
Increased by 26.18%
Revenue Next Year
794.48M
from 657.80M
Increased by 20.78%
EPS This Year
-1.80
from -0.47
EPS Next Year
-0.11
from -1.80
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 690.5M | 883.9M | ||||||
| Avg | 657.8M | 794.5M | ||||||
| Low | 617.4M | 681.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 32.5% | 34.4% | ||||||
| Avg | 26.2% | 20.8% | ||||||
| Low | 18.4% | 3.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.37 | 1.00 | ||||||
| Avg | -1.80 | -0.11 | ||||||
| Low | -2.76 | -1.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.